Merck agrees to pay $41.1B to take over Schering-Plough

Merck & Co. announced that it is acquiring Schering-Plough in a $41.1 billion deal that would grant Merck access to Schering-Plough's robust biotech, consumer-health and animal-health businesses. Merck CEO Richard Clark called the merger a "transformational event" that would put his company "at the forefront of drug discovery for years to come."

View Full Article in:

Wall Street Journal, The · Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA